DouglasNeyDouglas E Ney39.74528180000000-104.837572700000003309Ney, DouglasE303/724-2191Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 121641925585784Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Bar?n AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BDInternational journal of radiation oncology, biology, physicsRusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Bar?n AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):894-902.Int J Radiat Oncol Biol Phys2014-10-18T00:00:002014The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.Authorship 122490125524817Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen CJournal of neuro-oncologyNey DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar; 122(1):135-43.J Neurooncol2014-12-19T00:00:002014Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.Authorship 125567425920710Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen CJournal of neuro-oncologyCarlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun; 123(2):251-7.J Neurooncol2015-04-29T00:00:002015Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials.Authorship 130874326352990Schowinsky J, Leppert M, Ney D, Kleinschmidt-DeMasters BKJournal of neuropathology and experimental neurologySchowinsky J, Leppert M, Ney D, Kleinschmidt-DeMasters BK. Prominent Vascular and Perivascular Eosinophilic Infiltrates Heralding CNS Mycosis Fungoides. J Neuropathol Exp Neurol. 2015 Oct; 74(10):948-51.J Neuropathol Exp Neurol2015-10-01T00:00:002015Prominent Vascular and Perivascular Eosinophilic Infiltrates Heralding CNS Mycosis Fungoides.Authorship 98601RichardHughesRichard L Hughes39.74528180000000-104.8375727000000010763Hughes, RichardProfessorAuthorship 144497427214765Rusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BDJAMA neurologyRusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BD. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA Neurol. 2016 07 01; 73(7):821-8.JAMA Neurol2016-07-01T00:00:002016Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.5Other Faculty1Professor2Assoc Professor4InstructorAlmaYumAlma Yum39.74528180000000-104.8375727000000012840Yum, AlmaAffiliate - DHHA19080743Ney DE, Lassman ABCurrent oncology reportsNey DE, Lassman AB. Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions. Curr Oncol Rep. 2009 Jan; 11(1):62-7.Curr Oncol Rep2009-01-01T00:00:002009Molecular profiling of oligodendrogliomas: impact on prognosis, treatment, and future directions.AmandaPiquetAmanda Lee Piquet39.74528180000000-104.8375727000000013035Piquet, AmandaAssociate Professor19637086Ney DE, Abrey LELeukemia & lymphomaNey DE, Abrey LE. Maintenance therapy for central nervous system lymphoma with rituximab. Leuk Lymphoma. 2009 Sep; 50(9):1548-51.Leuk Lymphoma2009-09-01T00:00:002009Maintenance therapy for central nervous system lymphoma with rituximab.Authorship 166659328753117Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DRJournal of neurosurgeryOushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR. New-onset seizure during and after brain tumor excision: a risk assessment analysis. J Neurosurg. 2018 06; 128(6):1713-1718.J Neurosurg2017-07-28T00:00:002017New-onset seizure during and after brain tumor excision: a risk assessment analysis.19917990Green RM, Cloughesy TF, Stupp R, DeAngelis LM, Woyshner EA, Ney DE, Lassman ABNeurologyGreen RM, Cloughesy TF, Stupp R, DeAngelis LM, Woyshner EA, Ney DE, Lassman AB. Bevacizumab for recurrent ependymoma. Neurology. 2009 Nov 17; 73(20):1677-80.Neurology2009-11-17T00:00:002009Bevacizumab for recurrent ependymoma.20207611Ney DE, Huse JT, Dunkel IJ, Steinherz PG, Haque S, Khakoo YJournal of child neurologyNey DE, Huse JT, Dunkel IJ, Steinherz PG, Haque S, Khakoo Y. Intraventricular meningioma after cranial irradiation for childhood leukemia. J Child Neurol. 2010 Oct; 25(10):1292-5.J Child Neurol2010-03-05T00:00:002010Intraventricular meningioma after cranial irradiation for childhood leukemia.20572045Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LECancerNey DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Cancer. 2010 Oct 01; 116(19):4605-12.Cancer2010-10-01T00:00:002010Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.13001 East 17th Place2SOMSchool of Medicine13001 East 17th PlaceAurora80045-2570CO22547311Khalil A, Serracino H, Damek DM, Ney D, Lillehei KO, Kleinschmidt-DeMasters BKJournal of neuro-oncologyKhalil A, Serracino H, Damek DM, Ney D, Lillehei KO, Kleinschmidt-DeMasters BK. Genetic characterization of gliomas arising in patients with multiple sclerosis. J Neurooncol. 2012 Sep; 109(2):261-72.J Neurooncol2012-05-01T00:00:002012Genetic characterization of gliomas arising in patients with multiple sclerosis.22483738Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen CInternational journal of radiation oncology, biology, physicsReddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012 Nov 01; 84(3):655-60.Int J Radiat Oncol Biol Phys2012-04-05T00:00:002012Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme.Authorship 1771791029470304Nguyen GH, Mohler A, Leppert M, Parra C, Zeng YP, Prok L, Schowinsky J, Magro CM, Pacheco T, Ney DThe American Journal of dermatopathologyNguyen GH, Mohler A, Leppert M, Parra C, Zeng YP, Prok L, Schowinsky J, Magro CM, Pacheco T, Ney D. Index Case of Cutaneous Follicular Mycosis Fungoides With Central Nervous System Involvement and Review of Literature. Am J Dermatopathol. 2018 Mar; 40(3):185-190.Am J Dermatopathol2018-03-01T00:00:002018Index Case of Cutaneous Follicular Mycosis Fungoides With Central Nervous System Involvement and Review of Literature.Authorship 1774631029500290Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DENeurologyJordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality improvement in neurology: Neuro-oncology quality measurement set. Neurology. 2018 04 03; 90(14):652-658.Neurology2018-03-02T00:00:002018Quality improvement in neurology: Neuro-oncology quality measurement set.Authorship 1779401029509930Jordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DENeuro-oncologyJordan JT, Sanders AE, Armstrong T, Asher T, Bennett A, Dunbar E, Mohile N, Nghiemphu PL, Smith TR, Ney DE. Quality improvement in neurology: Neuro-Oncology Quality Measurement Set. Neuro Oncol. 2018 03 27; 20(4):531-537.Neuro Oncol2018-03-27T00:00:002018Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.Authorship 179209229618103Ung TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DRNeurosurgeryUng TH, Ney DE, Damek D, Rusthoven CG, Youssef AS, Lillehei KO, Ormond DR. The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma. Neurosurgery. 2019 03 01; 84(3):687-695.Neurosurgery2019-03-01T00:00:002019The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients With Primary Glioblastoma.D016543Disorders561290.856493Central Nervous System NeoplasmsD001932Disorders23210160.547325Brain NeoplasmsAuthorship 194191430665912Johnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJNeurologyJohnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJ. Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging. Neurology. 2019 01 22; 92(4):199-203.Neurology2019-01-22T00:00:002019Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging.D009462Occupations49950.880763NeurologySOM-OB/GYN GONC GENERAL OPSONC GENERAL OPERATIONSAbbiePennettiAbbie Pennetti39.74528180000000-104.8375727000000015700Pennetti, AbbieInstructorD009182Disorders20630.966815Mycosis FungoidesAuthorship 204912231341717Khan M, Ney DE, Kleinschmidt-DeMasters BK, Horton L, Alvarez E, Piquet ALNeurology. Clinical practiceKhan M, Ney DE, Kleinschmidt-DeMasters BK, Horton L, Alvarez E, Piquet AL. CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Neurol Clin Pract. 2019 Jun; 9(3):273-276.Neurol Clin Pract2019-06-01T00:00:002019CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab.D005909Disorders912620.803089GlioblastomaSOM-NEUR General OperationsSOM-NS General OperationsSOM-RADONC General OperationsSOM-MEDSOM-PEDSHematologyOncUniversity of Colorado Denver - Anschutz Medical CampusLaurieGasparLaurie Elizabeth Gaspar39.74273230000000-104.83919140000000148Gaspar, LaurieProfessor-Clinical KianBehbakhtKian Behbakht39.74403280000000-104.840810400000001735Behbakht, KianProfessorBrianKavanaghBrian D Kavanagh39.74273230000000-104.839191400000001609Kavanagh, BrianProfessorEugeneKronbergEugene Kronberg39.74528180000000-104.837572700000001881Kronberg, EugeneResearch AssociateDavidCamidgeDavid Ross Camidge39.74273230000000-104.839191400000002375Camidge, DavidProfessorAuthorship 111281DeniseDamekDenise Marie Damek39.74403280000000-104.84081040000000737Damek, DeniseProfessorNicholasForemanNicholas K Foreman39.74403510000000-104.83605940000000664Foreman, NicholasProfessor2.187470.00972787141research areas0.5092410.032480426coauthor of34.76693.860460similar to1132selected publicationsDebraO'ReillyDebra O'Reilly39.74528180000000-104.837572700000005739O'Reilly, DebraSenior InstructorAuthorship 98353623729276Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen CJournal of neuro-oncologyReddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug; 114(1):111-6.J Neurooncol2013-06-02T00:00:002013Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.Authorship 210131231613698Kluger BM, Ney DE, Bagley SJ, Mohile N, Taylor LP, Walbert T, Jones CAJournal of palliative medicineKluger BM, Ney DE, Bagley SJ, Mohile N, Taylor LP, Walbert T, Jones CA. Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain Cancer. J Palliat Med. 2020 03; 23(3):415-421.J Palliat Med2019-10-15T00:00:002019Top Ten Tips Palliative Care Clinicians Should Know When Caring for Patients with Brain Cancer.Authorship 218410632277236Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, Olar A, Schiff D, Shih HA, Strowd R, van den Bent MJ, Ziu MNeuro-oncologyMohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, Olar A, Schiff D, Shih HA, Strowd R, van den Bent MJ, Ziu M. Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic. Neuro Oncol. 2020 Apr 11.Neuro Oncol2020-04-11T00:00:002020Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.Authorship 220655232416558Kapadia RK, Ney DE, Hannan M, Farley M, Pastula DM, Piquet ALJournal of neuroimmunologyKapadia RK, Ney DE, Hannan M, Farley M, Pastula DM, Piquet AL. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab. J Neuroimmunol. 2020 07 15; 344:577259.J Neuroimmunol2020-05-07T00:00:002020Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.Authorship 222048232549952Kapadia RK, Ney DThe NeurohospitalistKapadia RK, Ney D. Stabilization of Progressive Multifocal Leukoencephalopathy After Pembrolizumab Treatment. Neurohospitalist. 2020 Jul; 10(3):238-239.Neurohospitalist2020-02-04T00:00:002020Stabilization of Progressive Multifocal Leukoencephalopathy After Pembrolizumab Treatment.Authorship 228221232999736Daniel EB, Ney DE, Levy JMMClinical case reports and reviewsDaniel EB, Ney DE, Levy JMM. MEK inhibition with trametinib is a successful therapy in ganglioglioma. Clin Case Rep Rev. 2020 Jun; 6(2).Clin Case Rep Rev2020-05-08T00:00:002020MEK inhibition with trametinib is a successful therapy in ganglioglioma.Authorship 2543856Authorship 254148734898238Mohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley JJournal of clinical oncology : official journal of the American Society of Clinical OncologyMohile NA, Messersmith H, Gatson NT, Hottinger AF, Lassman A, Morton J, Ney D, Nghiemphu PL, Olar A, Olson J, Perry J, Portnow J, Schiff D, Shannon A, Shih HA, Strowd R, van den Bent M, Ziu M, Blakeley J. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline. J Clin Oncol. 2022 02 01; 40(4):403-426.J Clin Oncol2021-12-13T00:00:002021Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.34934868Shiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DEAdvances in radiation oncologyShiao JC, Wolf AB, Rabinovitch RA, Smith C, Kleinschmidt-DeMasters BK, Ney DE. Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy. Adv Radiat Oncol. 2022 Mar-Apr; 7(2):100831.Adv Radiat Oncol2021-10-21T00:00:002021Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy.Authorship 256570235116570Fakhoury KR, Ney DE, Ormond DR, Rusthoven CGTranslational cancer researchFakhoury KR, Ney DE, Ormond DR, Rusthoven CG. Immunotherapy and radiation for high-grade glioma: a narrative review. Transl Cancer Res. 2021 May; 10(5):2537-2570.Transl Cancer Res2021-05-01T00:00:002021Immunotherapy and radiation for high-grade glioma: a narrative review.Authorship 263248235689567Schindler SE, Ney DE, Goss AL, Rabinovici GAnnals of neurologySchindler SE, Ney DE, Goss AL, Rabinovici G. ANA Investigates: The Future of Biomarkers in Alzheimer Disease. Ann Neurol. 2022 08; 92(2):159-160.Ann Neurol2022-06-30T00:00:002022ANA Investigates: The Future of Biomarkers in Alzheimer Disease.Authorship 28049114Authorship 2805721236965007David KA, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Bond DA, Agrawal P, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Folstad M, Kumar P, Ollila TA, Cai J, Spurgeon S, Sieg A, Cleveland J, Chang J, Epperla N, Karmali R, Naik S, Martin P, Smith SM, Rubenstein J, Kahl B, Evens AMAmerican journal of hematologyDavid KA, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Bond DA, Agrawal P, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Folstad M, Kumar P, Ollila TA, Cai J, Spurgeon S, Sieg A, Cleveland J, Chang J, Epperla N, Karmali R, Naik S, Martin P, Smith SM, Rubenstein J, Kahl B, Evens AM. Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers. Am J Hematol. 2023 06; 98(6):900-912.Am J Hematol2023-04-05T00:00:002023Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.36960939Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Gandhi MK, Keane C, Bond DA, Folstad M, Chang J, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Matnani R, Kumar P, Ollila TA, Cai J, Spurgeon SE, Sieg AG, Cleveland J, Epperla N, Karmali R, Naik S, Smith SM, Rubenstein JL, Kahl BS, Chadburn A, Evens AM, Martin PLeukemia & lymphomaAgrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanova V, Salman S, Vendiola JA, Hossain N, Tsang M, Major A, Gandhi MK, Keane C, Bond DA, Folstad M, Chang J, Mier-Hicks A, Torka P, Rajakumar P, Venugopal P, Berg S, Glantz M, Goldlust SA, Matnani R, Kumar P, Ollila TA, Cai J, Spurgeon SE, Sieg AG, Cleveland J, Epperla N, Karmali R, Naik S, Smith SM, Rubenstein JL, Kahl BS, Chadburn A, Evens AM, Martin P. EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort. Leuk Lymphoma. 2023 05; 64(5):1026-1034.Leuk Lymphoma2023-03-24T00:00:002023EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.true1ProfessorProfessortrue1ProfessorProfessortrue1InstructorInstructortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professor2Assoc ChairAssoc Chairtrue1Research AssociateResearch Associatetrue1Senior InstructorSenior Instructortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Professor-Clinical Professor-Clinical true1ProfessorProfessortrue1Affiliate - DHHAAffiliate - DHHAAuthorship 401014DOrmondD Ryan Ormond39.74528180000000-104.837572700000008973Ormond, DAssociate ProfessorAuthorship 645286Authorship 113761125045381Ney DE, Messersmith W, Behbakht KJournal of clinical neurology (Seoul, Korea)Ney DE, Messersmith W, Behbakht K. Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancer. J Clin Neurol. 2014 Jul; 10(3):262-6.J Clin Neurol2014-07-03T00:00:002014Anti-ma2 paraneoplastic encephalitis in association with recurrent cervical cancer.Authorship 685044Authorship 71281Authorship 754851